NDC properties for "0.4 ML Yuflyma 100 MG/ML Prefilled Syringe" (RxCUI 2639662)
About this data
The tables show NDC propoerties for 0.4 ML Yuflyma 100 MG/ML Prefilled Syringe with the RxCUI 2639662
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for 0.4 ML Yuflyma 100 MG/ML Prefilled Syringe (RxCUI 2639662)
| BLA | BLA761219 |
|---|---|
| MMSL_CODE | BD39482 |
| RxCUI | 2639662 |
| SPL_SET_ID | 526d626f-8c9f-496c-b838-00a73bb36383 |
| Prescribable Synonym | Yuflyma 40 MG in 0.4 ML Prefilled Syringe |
| RXNAV_STR | 0.4 ML Yuflyma 100 MG/ML Prefilled Syringe |
| RxNorm Name | 0.4 ML adalimumab-aaty 100 MG/ML Prefilled Syringe [Yuflyma] |
| RxNorm Synonym | 0.4 ML Yuflyma 100 MG/ML Prefilled Syringe |
| RxNorm Synonym | Yuflyma 40 MG per 0.4 ML Prefilled Syringe |
| Related queries | Interactions (for RxCUI 2639662) |
NDC Properties
NDC Item 72606003001
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-01 |
| NDC Item | 72606003001 |
| Packaging | 1 SYRINGE in 1 CARTON (72606-030-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003002
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-02 |
| NDC Item | 72606003002 |
| Packaging | 2 SYRINGE in 1 CARTON (72606-030-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003003
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-03 |
| NDC Item | 72606003003 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-030-03) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003004
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-04 |
| NDC Item | 72606003004 |
| Packaging | 6 SYRINGE in 1 CARTON (72606-030-04) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003005
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-05 |
| NDC Item | 72606003005 |
| Packaging | 1 SYRINGE in 1 CARTON (72606-030-05) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003006
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-06 |
| NDC Item | 72606003006 |
| Packaging | 2 SYRINGE in 1 CARTON (72606-030-06) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003007
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-07 |
| NDC Item | 72606003007 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-030-07) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003008
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-08 |
| NDC Item | 72606003008 |
| Packaging | 6 SYRINGE in 1 CARTON (72606-030-08) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003001
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-01 |
| NDC Item | 72606003001 |
| Packaging | 1 SYRINGE in 1 CARTON (72606-030-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003002
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-02 |
| NDC Item | 72606003002 |
| Packaging | 2 SYRINGE in 1 CARTON (72606-030-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003003
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-03 |
| NDC Item | 72606003003 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-030-03) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003004
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-04 |
| NDC Item | 72606003004 |
| Packaging | 6 SYRINGE in 1 CARTON (72606-030-04) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003005
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-05 |
| NDC Item | 72606003005 |
| Packaging | 1 SYRINGE in 1 CARTON (72606-030-05) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003006
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-06 |
| NDC Item | 72606003006 |
| Packaging | 2 SYRINGE in 1 CARTON (72606-030-06) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003007
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-07 |
| NDC Item | 72606003007 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-030-07) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003008
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-08 |
| NDC Item | 72606003008 |
| Packaging | 6 SYRINGE in 1 CARTON (72606-030-08) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003001
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-01 |
| NDC Item | 72606003001 |
| Packaging | 1 SYRINGE in 1 CARTON (72606-030-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003002
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-02 |
| NDC Item | 72606003002 |
| Packaging | 2 SYRINGE in 1 CARTON (72606-030-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003003
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-03 |
| NDC Item | 72606003003 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-030-03) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003004
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-04 |
| NDC Item | 72606003004 |
| Packaging | 6 SYRINGE in 1 CARTON (72606-030-04) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003005
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-05 |
| NDC Item | 72606003005 |
| Packaging | 1 SYRINGE in 1 CARTON (72606-030-05) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003006
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-06 |
| NDC Item | 72606003006 |
| Packaging | 2 SYRINGE in 1 CARTON (72606-030-06) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003007
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-07 |
| NDC Item | 72606003007 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-030-07) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003008
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-08 |
| NDC Item | 72606003008 |
| Packaging | 6 SYRINGE in 1 CARTON (72606-030-08) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003001
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-01 |
| NDC Item | 72606003001 |
| Packaging | 1 SYRINGE in 1 CARTON (72606-030-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003002
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-02 |
| NDC Item | 72606003002 |
| Packaging | 2 SYRINGE in 1 CARTON (72606-030-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003003
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-03 |
| NDC Item | 72606003003 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-030-03) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003004
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-04 |
| NDC Item | 72606003004 |
| Packaging | 6 SYRINGE in 1 CARTON (72606-030-04) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003005
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-05 |
| NDC Item | 72606003005 |
| Packaging | 1 SYRINGE in 1 CARTON (72606-030-05) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003006
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-06 |
| NDC Item | 72606003006 |
| Packaging | 2 SYRINGE in 1 CARTON (72606-030-06) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003007
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-07 |
| NDC Item | 72606003007 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-030-07) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003008
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-08 |
| NDC Item | 72606003008 |
| Packaging | 6 SYRINGE in 1 CARTON (72606-030-08) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003001
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-01 |
| NDC Item | 72606003001 |
| Packaging | 1 SYRINGE in 1 CARTON (72606-030-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003002
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-02 |
| NDC Item | 72606003002 |
| Packaging | 2 SYRINGE in 1 CARTON (72606-030-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003003
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-03 |
| NDC Item | 72606003003 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-030-03) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003004
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-04 |
| NDC Item | 72606003004 |
| Packaging | 6 SYRINGE in 1 CARTON (72606-030-04) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003005
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-05 |
| NDC Item | 72606003005 |
| Packaging | 1 SYRINGE in 1 CARTON (72606-030-05) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003006
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-06 |
| NDC Item | 72606003006 |
| Packaging | 2 SYRINGE in 1 CARTON (72606-030-06) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003007
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-07 |
| NDC Item | 72606003007 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-030-07) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003008
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-08 |
| NDC Item | 72606003008 |
| Packaging | 6 SYRINGE in 1 CARTON (72606-030-08) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003001
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-01 |
| NDC Item | 72606003001 |
| Packaging | 1 SYRINGE in 1 CARTON (72606-030-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003002
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-02 |
| NDC Item | 72606003002 |
| Packaging | 2 SYRINGE in 1 CARTON (72606-030-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003003
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-03 |
| NDC Item | 72606003003 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-030-03) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003004
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-04 |
| NDC Item | 72606003004 |
| Packaging | 6 SYRINGE in 1 CARTON (72606-030-04) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003005
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-05 |
| NDC Item | 72606003005 |
| Packaging | 1 SYRINGE in 1 CARTON (72606-030-05) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003006
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-06 |
| NDC Item | 72606003006 |
| Packaging | 2 SYRINGE in 1 CARTON (72606-030-06) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003007
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-07 |
| NDC Item | 72606003007 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-030-07) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003008
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-08 |
| NDC Item | 72606003008 |
| Packaging | 6 SYRINGE in 1 CARTON (72606-030-08) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003001
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-01 |
| NDC Item | 72606003001 |
| Packaging | 1 SYRINGE in 1 CARTON (72606-030-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003002
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-02 |
| NDC Item | 72606003002 |
| Packaging | 2 SYRINGE in 1 CARTON (72606-030-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003003
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-03 |
| NDC Item | 72606003003 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-030-03) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003004
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-04 |
| NDC Item | 72606003004 |
| Packaging | 6 SYRINGE in 1 CARTON (72606-030-04) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003005
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-05 |
| NDC Item | 72606003005 |
| Packaging | 1 SYRINGE in 1 CARTON (72606-030-05) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003006
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-06 |
| NDC Item | 72606003006 |
| Packaging | 2 SYRINGE in 1 CARTON (72606-030-06) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003007
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-07 |
| NDC Item | 72606003007 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-030-07) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003008
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-08 |
| NDC Item | 72606003008 |
| Packaging | 6 SYRINGE in 1 CARTON (72606-030-08) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003001
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-01 |
| NDC Item | 72606003001 |
| Packaging | 1 SYRINGE in 1 CARTON (72606-030-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003002
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-02 |
| NDC Item | 72606003002 |
| Packaging | 2 SYRINGE in 1 CARTON (72606-030-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003003
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-03 |
| NDC Item | 72606003003 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-030-03) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003004
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-04 |
| NDC Item | 72606003004 |
| Packaging | 6 SYRINGE in 1 CARTON (72606-030-04) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003005
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-05 |
| NDC Item | 72606003005 |
| Packaging | 1 SYRINGE in 1 CARTON (72606-030-05) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003006
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-06 |
| NDC Item | 72606003006 |
| Packaging | 2 SYRINGE in 1 CARTON (72606-030-06) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003007
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-07 |
| NDC Item | 72606003007 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-030-07) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003008
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-08 |
| NDC Item | 72606003008 |
| Packaging | 6 SYRINGE in 1 CARTON (72606-030-08) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |